Target Price | $183.60 |
Price | $131.24 |
Potential |
39.90%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target ICU Medical, Inc. 2026 .
The average ICU Medical, Inc. target price is $183.60.
This is
39.90%
register free of charge
$200.55
52.81%
register free of charge
$146.45
11.59%
register free of charge
|
|
A rating was issued by 12 analysts: 10 Analysts recommend ICU Medical, Inc. to buy, 2 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the ICU Medical, Inc. stock has an average upside potential 2026 of
39.90%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.38 | 2.24 |
5.44% | 6.13% | |
EBITDA Margin | 4.36% | 17.63% |
51.41% | 303.96% | |
Net Margin | -4.94% | 7.87% |
276.32% | 259.29% |
9 Analysts have issued a sales forecast ICU Medical, Inc. 2025 . The average ICU Medical, Inc. sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an ICU Medical, Inc. EBITDA forecast 2025. The average ICU Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 ICU Medical, Inc. Analysts have issued a net profit forecast 2025. The average ICU Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -4.83 | 7.13 |
292.68% | 247.62% | |
P/E | 18.41 | |
EV/Sales | 1.92 |
9 Analysts have issued a ICU Medical, Inc. forecast for earnings per share. The average ICU Medical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
ICU Medical, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 15 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | May 09 2025 |
Keybanc |
Locked
➜
Locked
|
Locked | Apr 21 2025 |
Needham |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
Jefferies |
Locked
➜
Locked
|
Locked | Dec 11 2024 |
Keybanc |
Locked
➜
Locked
|
Locked | Nov 13 2024 |
Analyst Rating | Date |
---|---|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 15 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Aug 08 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
May 09 2025 |
Locked
Keybanc:
Locked
➜
Locked
|
Apr 21 2025 |
Locked
Needham:
Locked
➜
Locked
|
Apr 08 2025 |
Locked
Jefferies:
Locked
➜
Locked
|
Dec 11 2024 |
Locked
Keybanc:
Locked
➜
Locked
|
Nov 13 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.